Skip to main content
FinSpry Logo
FinSpry
KZIA logo
KZIA
(NASDAQ)
Kazia Therapeutics Limited
$12.56-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Kazia Therapeutics (KZIA) Stock Price & Financial Analysis

Kazia Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$11.72 - $12.55
52-Week High$17.40
52-Week Low$3.22
Open$12.40
Volume271.26K
Average Volume (3M)274.73K
Market Cap39.19M
Shares Outstanding3.12M
Price to Sales (P/S)22.83
Price to Book (P/B)1.24
EV/EBITDA0.26
Revenue (TTM)1.80M
Net Income (TTM)-36.13M
Free Cash Flow (TTM)-17.69M
EPS (TTM)$-23.70
Profit Margin-2008.78%
Operating Margin-1866.72%
Return on Equity (ROE)-109.07%
Debt to Equity0.00
50-Day MA$9.80
200-Day MA$8.30
52-Week Change295.96%
Annual Dividend$0.00
Dividend Yield0.00%
Last Dividend Ex-DateJan 28, 2013

Frequently Asked Questions About Kazia Therapeutics

What is the current stock price for KZIA?

As of the latest trading session, KZIA stock trades at $12.08. The 52-week range is $3.22–$17.40, with a day range of $11.72–$12.55.

What is the P/E ratio for KZIA?

The P/E ratio (Price-to-Earnings) for KZIA is shown in the Key Statistics section. This valuation metric helps compare Kazia Therapeutics Limited to industry peers.

Does KZIA pay dividends?

Kazia Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for KZIA?

Based on 1 analyst, the consensus for KZIA is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of KZIA?

Kazia Therapeutics's market capitalization is $37.7M, classifying it as a micro-cap company. Kazia Therapeutics operates in the Healthcare sector within the Biotechnology industry.